Cardiol Therapeutics
Oakville, CanadaFounded 2017
About Cardiol Therapeutics
Cardiol Therapeutics is an Oakville, Ontario-based clinical-stage biopharmaceutical company focused on developing cannabidiol (CBD) based therapies for heart disease. The company is pursuing a novel approach to treating cardiovascular inflammation using pharmaceutical-grade CBD formulations.
Key Facts
- 1Developing pharmaceutical-grade CBD for the treatment of heart disease and cardiovascular inflammation
- 2CardiolRx is an ultra-pure, pharmaceutically manufactured CBD formulation
- 3Conducting clinical trials investigating CBD for acute myocarditis and other cardiac conditions
- 4One of the few companies focused on cannabinoid applications in cardiology
Frequently Asked Questions
Can CBD treat heart disease?
Cardiol Therapeutics is investigating whether pharmaceutical-grade CBD can reduce cardiovascular inflammation. Their clinical trials are studying CBD's potential anti-inflammatory and anti-fibrotic effects in cardiac conditions like myocarditis.
What is CardiolRx?
CardiolRx is Cardiol Therapeutics' proprietary pharmaceutical-grade cannabidiol formulation, manufactured to pharmaceutical standards for use in clinical trials targeting cardiovascular disease.
Products
- CardiolRx (pharmaceutical CBD formulation)
- CRD-38 (anti-fibrotic candidate)
- Cardiovascular cannabinoid therapies
Specialties
Cannabinoid cardiovascular therapeuticsPharmaceutical-grade CBD developmentAnti-inflammatory cannabinoid researchClinical-stage drug development
Company Details
- Type
- Medical & Pharma
- Location
- Oakville, Canada
- Founded
- 2017
- Publicly Traded
- No
Browse all Medical & Pharma
View more companies in this category
Related Companies
More in Canada
Tilray Brands
Leamington \u2014 Producer & Grower
Canopy Growth
Smiths Falls \u2014 Producer & Grower
Aurora Cannabis
Edmonton \u2014 Producer & Grower
Cronos Group
Toronto \u2014 Producer & Grower